Description: Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.
Home Page: www.labcorp.com
0JSY Technical Analysis
358 South Main Street
Burlington,
NC
27215
United States
Phone:
336 229 1127
Officers
| Name | Title |
|---|---|
| Mr. Adam H. Schechter | President, CEO & Chairman |
| Mr. Mark S. Schroeder | Executive VP, President of Diagnostics Laboratories & COO |
| Dr. Brian J. Caveney J.D., M.D., M.P.H. | EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer |
| Ms. Anita Z. Graham | Executive VP & Chief Human Resources Officer |
| Mr. Glenn A. Eisenberg | Special Advisor to the CEO |
| Ms. Julia Wang | CFO & Executive VP |
| Mr. Peter J. Wilkinson | Senior VP & Chief Accounting Officer |
| Christin O'Donnell | Vice President of Investor Relations |
| Ms. Sandra D. van der Vaart J.D. | Executive VP, Chief Legal Officer & Corporate Secretary |
| Dr. Marcia T. Eisenberg Ph.D. | Enterprise Chief Scientific Officer & Senior VP |
Exchange: LSE
Country: GB : United Kingdom of Great Britain and Northern Ireland
Currency: US Dollar ($)
| GIC Sector: | Industrials |
|---|---|
| GIC Group: | Commercial & Professional Services |
| GIC Industry: | Commercial Services & Supplies |
| GIC Sub-Industry: | Environmental & Facilities Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0.1066 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1.812 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 67000 |